1. Home
  2. ALLO vs SNFCA Comparison

ALLO vs SNFCA Comparison

Compare ALLO & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.63

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

HOLD

Current Price

$8.94

Market Cap

234.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
SNFCA
Founded
2017
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
234.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALLO
SNFCA
Price
$1.63
$8.94
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
$8.27
N/A
AVG Volume (30 Days)
4.2M
36.8K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.74
Revenue
N/A
$340,876,482.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$11.77
Revenue Growth
N/A
3.25
52 Week Low
$0.86
$7.32
52 Week High
$3.78
$12.83

Technical Indicators

Market Signals
Indicator
ALLO
SNFCA
Relative Strength Index (RSI) 59.70 52.48
Support Level $1.62 $8.68
Resistance Level $1.88 $8.98
Average True Range (ATR) 0.11 0.27
MACD 0.02 -0.01
Stochastic Oscillator 56.41 58.33

Price Performance

Historical Comparison
ALLO
SNFCA

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

Share on Social Networks: